Prenetics Global (NASDAQ:PRE) Given Overweight Rating at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Prenetics Global (NASDAQ:PRE) in a report released on Thursday,Benzinga reports. They currently have a $9.00 target price on the stock.

Prenetics Global Price Performance

Prenetics Global stock opened at $5.93 on Thursday. Prenetics Global has a fifty-two week low of $2.85 and a fifty-two week high of $7.84. The stock’s fifty day moving average is $5.19 and its two-hundred day moving average is $5.09.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.